secwatch / observer
8-K filed June 1, 2026, 9:12 AM ET ticker GPRO CIK 0001500435
other material confidence high sentiment negative materiality 0.90

GoPro refiles financials with going-concern warning; potential defaults on debt

GoPro, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001628280-26-039297
form_type
8-K
ticker
GPRO
cik
0001500435
company_name
GoPro, Inc.
filed_at
2026-06-01T13:12:22+00:00
discovered_at
2026-06-01T13:13:00.302098+00:00
generated_at
2026-06-01T13:13:14.330556+00:00
sec_items
["8.01", "9.01"]
event_type
other_material
sentiment
negative
materiality_score
0.9
calibrated_materiality_score
0.9
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001628280-26-039297
json_url
https://secwatch.observer/filing/0001628280-26-039297.json
markdown_url
https://secwatch.observer/filing/0001628280-26-039297.md
text_url
https://secwatch.observer/filing/0001628280-26-039297.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1500435/000162828026039297/0001628280-26-039297-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1500435/000162828026039297/gpro-20260601.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Comparable filings

OPTU

Optimum raises $500M via preferred units, starts $300M tender at $2.50 to shield assets from CSC debt

Optimum Communications, Inc. June 1, 2026, 8:16 AM ET other_material Items 1.01, 3.02, 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

STSS

Sharps Technology rebrands as SkyAI, pivots to AI finance platform for Global South

Sharps Technology Inc. June 1, 2026, 8:15 AM ET other_material Items 5.03, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EIKN

Eikon reports 63.1% ORR in Phase 2 NSCLC trial of EIK1001; PARP1 inhibitor EIK1003 shows 24.5% ORR with paclitaxel

Eikon Therapeutics, Inc. June 1, 2026, 7:30 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SMMT

Ivonescimab: 70.8% ORR in mCRC Phase II; HARMONi-6 OS HR 0.66 vs tislelizumab

Summit Therapeutics Inc. June 1, 2026, 6:57 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

JSPR

Jasper Therapeutics initiates strategic review including potential sale or wind-down

Jasper Therapeutics, Inc. June 1, 2026, 8:01 AM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

ZSPC

zSpace restructures $12M debt via equity conversion; creates Series P-2 preferred

zSpace, Inc. June 1, 2026, 8:00 AM ET other_material Items 1.01, 1.02, 2.03, 3.02, 5.03, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

SOC

Sable Offshore reports first reserve post-restart: 90.5 MMbbl proved developed oil, PV10 $1.47B

Sable Offshore Corp. June 1, 2026, 6:38 AM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001628280-26-039297

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.